Circular Intermediates of Recombinant Adeno-Associated Virus Have Defined Structural Characteristics Responsible for Long-Term Episomal Persistence in Muscle Tissue
- 1 November 1998
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 72 (11), 8568-8577
- https://doi.org/10.1128/jvi.72.11.8568-8577.1998
Abstract
Adeno-associated viral (AAV) vectors have demonstrated great utility for long-term gene expression in muscle tissue. However, the mechanisms by which recombinant AAV (rAAV) genomes persist in muscle tissue remain unclear. Using a recombinant shuttle vector, we have demonstrated that circularized rAAV intermediates impart episomal persistence to rAAV genomes in muscle tissue. The majority of circular intermediates had a consistent head-to-tail configuration consisting of monomer genomes which slowly converted to large multimers of >12 kbp by 80 days postinfection. Importantly, long-term transgene expression was associated with prolonged (80-day) episomal persistence of these circular intermediates. Structural features of these circular intermediates responsible for increased persistence included a DNA element encompassing two viral inverted terminal repeats (ITRs) in a head-to-tail orientation, which confers a 10-fold increase in the stability of DNA following incorporation into plasmid-based vectors and transfection into HeLa cells. These studies suggest that certain structural characteristics of AAV circular intermediates may explain long-term episomal persistence with this vector. Such information may also aid in the development of nonviral gene delivery systems with increased efficiency.Keywords
This publication has 48 references indexed in Scilit:
- Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectorsNature Genetics, 1997
- Recombinant Adeno-Associated Viral Vectors Mediate Long-Term Transgene Expression in MuscleHuman Gene Therapy, 1997
- Recombinant adeno-associated virus for muscle directed gene therapyNature Medicine, 1997
- Lack of Site-Specific Integration of the Recombinant Adeno-Associated Virus 2 Genomes in Human CellsHuman Gene Therapy, 1997
- Phenotypic correction of Fanconi anemia in human hematopoietic cells with a recombinant adeno-associated virus vector.Journal of Clinical Investigation, 1994
- Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brainNature Genetics, 1994
- Efficient and sustained gene expression in primary T lymphocytes and primary and cultured tumor cells mediated by adeno-associated virus plasmid DNA complexed to cationic liposomes.Molecular and Cellular Biology, 1994
- Use of Adeno-Associated Virus as a General Transduction Vector for Mammalian CellsPublished by Springer Nature ,1992
- Form and Function of Retroviral ProvirusesScience, 1982
- Selective extraction of polyoma DNA from infected mouse cell culturesJournal of Molecular Biology, 1967